Khalil Muhammad Ashhad Ullah, Patujo Yassar Hussain, Ullah Farman, Ibrar Usama, Adil Ruqqayia, Inam Qazi Adil, Zohaib Muhammad, Fatima Arooj, Asif Muhammad, Afnan Muhammad
Department of Urology, Institute of Kidney Diseases, Hayatabad Medical Complex, Peshawar, PAK.
Department of Urology, Chandka Medical College, Shaheed Mohtarma Benazir Bhutto Medical University, Larkana, PAK.
Cureus. 2024 Dec 9;16(12):e75430. doi: 10.7759/cureus.75430. eCollection 2024 Dec.
Percutaneous nephrolithotomy (PCNL) is the preferred treatment for large renal stones, yet variability in outcomes arises from patient-specific factors and institutional practices. Understanding complications and predictors of success is essential to improving procedural efficacy.
This study aimed to evaluate stone clearance rates, complications classified using the Clavien-Dindo system, and predictors of PCNL outcomes, with a focus on improving lower calyx stone clearance.
A retrospective analysis was conducted on 422 PCNL procedures performed from July 2021 to December 2023 at the Institute of Kidney Disease, Hayatabad Medical Complex, Peshawar, Pakistan. Patient demographics, stone characteristics, and postoperative outcomes were analyzed. Stone clearance rates were calculated, and complications were categorized by severity. Associations between patient and stone characteristics and outcomes were tested using Chi-square analysis, with significance set at p < 0.05.
A total of 422 PCNL cases were analyzed, with an overall stone-free rate of 75.82% (320/422). The average patient age was 45.39 ± 12.43 years, with male patients comprising 56.87% of the cohort and a mean BMI of 27.82 ± 4.21 kg/m². Hypertension (21.43%), diabetes mellitus (18.95%), and chronic kidney disease (7.11%) were notable comorbidities. Stones averaged 3.21 ± 1.13 cm in size, predominantly composed of calcium oxalate (35.55%), and were most frequently located in the upper calyx (28.44%). Postoperative outcomes revealed a 21.33% complication rate, with 16.59% classified as minor (Clavien-Dindo Grades I-II) and 4.74% as major (Grades III-IV). Follow-up data showed that 11.83% of patients had residual stone fragments, and 9.48% experienced delayed complications, primarily minor. Stone size and location significantly influenced outcomes, with clearance rates of 80.00% for 2-3 cm stones versus 65.57% for stones >3 cm (p = 0.155). Lower calyx stones had markedly reduced clearance rates (50.00%, p < 0.001) compared to upper (75.00%) and mid-calyx (70.00%) stones, while stones in multiple locations also showed poor clearance (57.69%, p = 0.001). Key predictors of complications included higher BMI and prolonged operative times, emphasizing the need for tailored approaches, technical refinements, and institutional audits to optimize outcomes for anatomically or clinically complex cases.
This study highlights the high efficacy of PCNL in managing large renal stones, achieving a stone-free rate of 75.82%. However, the findings underscore the significant challenges associated with lower calyx stones and larger stone sizes, both linked to reduced clearance rates. The Clavien-Dindo classification of complications shows that while minor complications are more frequent, major complications remain a concern, especially in patients with elevated BMI or prolonged operative times. To optimize outcomes, this study recommends refining surgical techniques and adopting technological advancements to improve lower calyx clearance, implementing institutional audits to standardize practices, and personalizing treatment strategies through preoperative risk stratification. Future multicenter prospective studies are needed to validate these findings, further explore predictors of outcomes, and develop comprehensive care protocols addressing anatomical and patient-specific challenges in PCNL procedures.
经皮肾镜取石术(PCNL)是治疗大型肾结石的首选方法,但由于患者个体因素和机构操作的差异,治疗结果存在变异性。了解并发症和成功的预测因素对于提高手术疗效至关重要。
本研究旨在评估结石清除率、使用Clavien-Dindo系统分类的并发症以及PCNL治疗结果的预测因素,重点是提高下盏结石的清除率。
对2021年7月至2023年12月在巴基斯坦白沙瓦哈亚塔巴德医疗中心肾病研究所进行的422例PCNL手术进行回顾性分析。分析患者的人口统计学特征、结石特征和术后结果。计算结石清除率,并按严重程度对并发症进行分类。使用卡方分析检验患者和结石特征与结果之间的关联,显著性设定为p < 0.05。
共分析了422例PCNL病例,总体无结石率为75.82%(320/422)。患者平均年龄为45.39 ± 12.43岁,男性患者占队列的56.87%,平均BMI为27.82 ± 4.21kg/m²。高血压(21.43%)、糖尿病(18.95%)和慢性肾脏病(7.11%)是显著的合并症。结石平均大小为3.21 ± 1.13cm,主要由草酸钙组成(35.55%),最常见于上盏(28.44%)。术后结果显示并发症发生率为21.33%,其中16.59%为轻度(Clavien-Dindo I-II级),4.74%为重度(III-IV级)。随访数据显示,11.83%的患者有残余结石碎片,9.48%发生延迟并发症,主要为轻度。结石大小和位置对结果有显著影响,2-3cm结石的清除率为80.00%,而>3cm结石的清除率为65.57%(p = 0.155)。与上盏(75.00%)和中盏(70.00%)结石相比,下盏结石的清除率显著降低(50.00%,p < 0.00),而多个部位的结石清除率也较低(57.69%,p = 0.001)。并发症的关键预测因素包括较高的BMI和较长的手术时间,强调需要采取个性化方法、技术改进和机构审核,以优化解剖或临床复杂病例的治疗结果。
本研究强调了PCNL治疗大型肾结石的高效性,无结石率达到75.82%。然而,研究结果强调了与下盏结石和较大结石尺寸相关的重大挑战,两者均与清除率降低有关。Clavien-Dindo并发症分类显示,虽然轻度并发症更常见,但重度并发症仍然令人担忧,尤其是在BMI升高或手术时间延长的患者中。为了优化治疗结果,本研究建议改进手术技术并采用技术进步以提高下盏清除率,实施机构审核以规范操作,并通过术前风险分层制定个性化治疗策略。未来需要多中心前瞻性研究来验证这些发现,进一步探索治疗结果的预测因素,并制定全面的护理方案,以应对PCNL手术中的解剖和患者特定挑战。